Article
Marfan syndrome: from gene to therapy.
Current opinion in pediatrics - 1 Aug 2012
Bolar Nikhita, Van Laer Lut, Loeys Bart L
Abstract excerpt
PURPOSE OF REVIEW: Although historically Marfan syndrome (MFS) has always been considered as a condition caused by the deficiency of a structural extracellular matrix protein, fibrillin-1, the study of Marfan mouse models and Marfan-related conditions has shifted our current understanding to a pathogenic model that involves dysregulation of the cytokine-transforming growth factor beta (TGF-β) signaling. RECENT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
